Novartis India Stock Offer Update: NIL Shares Tendered as of June 12, 2026

Novartis India Stock Offer Update: NIL Shares Tendered as of June 12, 2026​

Novartis India Limited is undergoing an open offer managed by multiple entities for the acquisition of a significant portion of its equity shares. The combined group of acquirers includes WaveRise Investments Limited, ChrysCapital Fund X (a scheme of ChrysCapital Trust I), and Two Infinity Partners. The acquiring consortium also features PAC 1 (ChrysCapital X, LLC) and PAC 2 (OceanEdge Investments Limited).

The open offer is focused on the acquisition of up to 64,19,608 fully paidup equity shares of Novartis India Limited. These shares represent 26% of the Voting Share Capital of the company and have a face value of INR 5 each.

A disclosure regarding the tender status of these equity shares was issued as of June 13, 2026. The report details the response received both in dematerialized form and through physical submission.

Tender Status Update​

The records show that zero Equity Shares were tendered on June 1, 2026, through the Open Offer Escrow Demat Account. Furthermore, as of June 12, 2026, NIL Equity Shares have been tendered in the physical form to the Registrar to the Open Offer.

This update reflects the status received from the Manager to the Open Offer covering both dematerialized and physical equity shares submissions by public shareholders. While the open offer permits acquisition up to 64,19,608 shares, the current tender statistics indicate no submissions in either format.

It is noted that any Equity Shares tendered by Public Shareholders are subject to validation and verification of all submitted documents. The number of shares tendered may differ from the number eventually accepted by the Acquirers in the Open Offer.

NOVARTIND Stock Price Movement​

Novartis India Limited shares slipped on Friday, shedding 1.71% to close at ₹1,301.60. The stock closed with a total traded volume of 13,186 shares.